Telemedicine Versus Face-to-Face Care in Ophthalmology: Costs and Utility Measures in a Real-World Setting
Overview
Authors
Affiliations
Objectives: Advances in telemedicine offer a unique opportunity to expand access to the health system. Nevertheless, few studies have described the impact of telediagnosis implementation on health and economic outcomes.
Methods: An ophthalmology telediagnosis service (TeleOftalmo) was compared with traditional face-to-face care provided by the Brazilian public health system. For both groups, utility data were collected at 2 time points using the Visual Function Questionnaire-Utility Index instrument from interviews with 536 patients. The cost per patient encounter was analyzed according to the time-driven activity-based costing. Value analyses were conducted to ascertain whether and how telemedicine service has the potential to generate cost savings for the health system.
Results: Visual function-related quality of life did not differ significantly between TeleOftalmo and face-to-face care groups. Using the current model, the telemedicine service assisted an average of 1159 patients per month at a median cost per telediagnosis of Int$97 (interquartile range, Int$82-Int$119) versus Int$77 (interquartile range, Int$75-Int$80) for face-to-face care. If the telemedicine service was redesigned, considering the opportunities for improvement identified, it could operate at a cost of Int$53 per telediagnosis (a 31% cost savings) and could serve 3882 patients per month.
Conclusions: This study demonstrates the potential value of a telemedicine service. There was no difference in patient-perceived utility between a telediagnostic ophthalmology service and face-to-face care by an eye specialist. TeleOftalmo has the potential to be a cost-saving strategy for the Brazilian health system and could be a template for implementation of telediagnostic services in other regions.
Oliveira C, Pires M, Meira K, de Jesus J, Borges I, Paixao M J Med Internet Res. 2024; 26:e48464.
PMID: 38857068 PMC: 11196913. DOI: 10.2196/48464.
Considerations of COVID-19 in Ophthalmology.
Salvetat M, Musa M, Pellegrini F, Salati C, Spadea L, Zeppieri M Microorganisms. 2023; 11(9).
PMID: 37764064 PMC: 10538084. DOI: 10.3390/microorganisms11092220.
Surfing the COVID-19 Tsunami with Teleophthalmology: the Advent of New Models of Eye Care.
Ricur G, Reyes J, Alfonso E, Marino R Curr Ophthalmol Rep. 2023; 11(1):1-12.
PMID: 36743397 PMC: 9883823. DOI: 10.1007/s40135-023-00308-9.
Abihaidar N, Thuret G, Gain P, Garcin T J Pers Med. 2022; 12(6).
PMID: 35743651 PMC: 9225171. DOI: 10.3390/jpm12060866.